Literature DB >> 16455074

Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition.

Tomoyuki Sumi1, Atsuko Hashigasako, Kunio Matsumoto, Toshikazu Nakamura.   

Abstract

LIM kinases (LIMK1 and LIMK2) regulate actin cytoskeletal reorganization through phosphorylating and inactivating cofilin, an actin-depolymerizing factor of actin filaments. Here, we describe a detailed analysis of the cell-cycle-dependent activity of LIMK2, and a subcellular localization of LIMK1 and LIMK2. The activity of LIMK2, distinct from LIMK1, toward cofilin phosphorylation did not change in the normal cell division cycle. In contrast, LIMK2 was hyperphosphorylated and its activity was markedly increased when HeLa cells were synchronized at mitosis with nocodazole treatment. Immunofluorescence analysis showed that LIMK1 was localized at cell-cell adhesion sites in interphase and prophase, redistributed to the spindle poles during prometaphase to anaphase, and accumulated at the cleavage furrow in telophase. In contrast, LIMK2 was diffusely localized in the cytoplasm during interphase, redistributed to the mitotic spindle, and finally to the spindle midzone during anaphase to telophase. These findings suggest that LIMK2 is activated in response to microtubule disruption, and that LIMK1 and LIMK2 may play different roles in regulating for the mitotic spindle organization, chromosome segregation, and cytokinesis during the cell division cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455074     DOI: 10.1016/j.yexcr.2005.12.030

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

2.  ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly.

Authors:  Rochelle Tixeira; Thanh Kha Phan; Sarah Caruso; Bo Shi; Georgia K Atkin-Smith; Christina Nedeva; Jenny D Y Chow; Hamsa Puthalakath; Mark D Hulett; Marco J Herold; Ivan K H Poon
Journal:  Cell Death Differ       Date:  2019-05-01       Impact factor: 15.828

Review 3.  And the dead shall rise: actin and myosin return to the spindle.

Authors:  Joshua C Sandquist; Angela M Kita; William M Bement
Journal:  Dev Cell       Date:  2011-09-13       Impact factor: 12.270

4.  Recognition of physiological phosphorylation sites by p21-activated kinase 4.

Authors:  Ashwin K Chetty; Joel A Sexton; Byung Hak Ha; Benjamin E Turk; Titus J Boggon
Journal:  J Struct Biol       Date:  2020-06-23       Impact factor: 2.867

5.  LIMK2 mediates resistance to chemotherapeutic drugs in neuroblastoma cells through regulation of drug-induced cell cycle arrest.

Authors:  Cristina Gamell; Alice V Schofield; Randy Suryadinata; Boris Sarcevic; Ora Bernard
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 6.  LIM kinases: function, regulation and association with human disease.

Authors:  Rebecca W Scott; Michael F Olson
Journal:  J Mol Med (Berl)       Date:  2007-02-10       Impact factor: 5.606

7.  YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.

Authors:  A H Davies; I Barrett; M R Pambid; K Hu; A L Stratford; S Freeman; I M Berquin; S Pelech; P Hieter; C Maxwell; S E Dunn
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

Review 8.  Connecting cell polarity signals to the cytokinetic machinery in yeast and metazoan cells.

Authors:  Joseph O Magliozzi; James B Moseley
Journal:  Cell Cycle       Date:  2021-01-05       Impact factor: 4.534

9.  Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation.

Authors:  Filipe C Lourenço; June Munro; Jennifer Brown; Julia Cordero; Rhoda Stefanatos; Karen Strathdee; Clare Orange; Stephan M Feller; Owen J Sansom; Marcos Vidal; Graeme I Murray; Michael F Olson
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

10.  Multimodal effects of small molecule ROCK and LIMK inhibitors on mitosis, and their implication as anti-leukemia agents.

Authors:  Yusuke Oku; Chiaki Tareyanagi; Shinichi Takaya; Sayaka Osaka; Haruki Ujiie; Kentaro Yoshida; Naoyuki Nishiya; Yoshimasa Uehara
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.